Fiera Capital (Canada)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-649
| Closed | -$534K | – | 533 |
|
2023
Q3 | $534K | Buy |
649
+15
| +2% | +$12.3K | ﹤0.01% | 415 |
|
2023
Q2 | $456K | Buy |
+634
| New | +$456K | ﹤0.01% | 438 |
|
2023
Q1 | – | Sell |
-846
| Closed | -$610K | – | 523 |
|
2022
Q4 | $610K | Sell |
846
-1,392
| -62% | -$1M | ﹤0.01% | 407 |
|
2022
Q3 | $1.54M | Sell |
2,238
-2,008
| -47% | -$1.38M | 0.01% | 332 |
|
2022
Q2 | $2.51M | Sell |
4,246
-97
| -2% | -$57.3K | 0.01% | 269 |
|
2022
Q1 | $3.03M | Sell |
4,343
-267
| -6% | -$186K | 0.01% | 269 |
|
2021
Q4 | $2.91M | Sell |
4,610
-762
| -14% | -$481K | 0.01% | 271 |
|
2021
Q3 | $3.25M | Buy |
5,372
+149
| +3% | +$90.2K | 0.01% | 233 |
|
2021
Q2 | $2.92M | Buy |
5,223
+1,004
| +24% | +$561K | 0.01% | 248 |
|
2021
Q1 | $2M | Buy |
4,219
+260
| +7% | +$123K | 0.01% | 291 |
|
2020
Q4 | $1.91M | Buy |
3,959
+2,994
| +310% | +$1.45M | 0.01% | 370 |
|
2020
Q3 | $541K | Sell |
965
-95
| -9% | -$53.3K | ﹤0.01% | 467 |
|
2020
Q2 | $660K | Buy |
+1,060
| New | +$660K | ﹤0.01% | 448 |
|
2018
Q4 | – | Sell |
-4,089
| Closed | -$1.65M | – | 717 |
|
2018
Q3 | $1.65M | Buy |
4,089
+304
| +8% | +$123K | 0.01% | 443 |
|
2018
Q2 | $1.31M | Sell |
3,785
-239
| -6% | -$82.5K | 0.01% | 450 |
|
2018
Q1 | $1.39M | Sell |
4,024
-16
| -0.4% | -$5.51K | 0.01% | 429 |
|
2017
Q4 | $1.52M | Sell |
4,040
-238
| -6% | -$89.5K | 0.01% | 404 |
|
2017
Q3 | $1.91M | Sell |
4,278
-1,693
| -28% | -$757K | 0.01% | 382 |
|
2017
Q2 | $2.93M | Sell |
5,971
-1,826
| -23% | -$897K | 0.01% | 353 |
|
2017
Q1 | $3.02M | Buy |
7,797
+50
| +0.6% | +$19.4K | 0.02% | 352 |
|
2016
Q4 | $2.84M | Sell |
7,747
-2,137
| -22% | -$785K | 0.02% | 408 |
|
2016
Q3 | $3.97M | Buy |
9,884
+692
| +8% | +$278K | 0.02% | 349 |
|
2016
Q2 | $3.21M | Buy |
9,192
+8,592
| +1,432% | +$3M | 0.02% | 381 |
|
2016
Q1 | $216K | Buy |
+600
| New | +$216K | ﹤0.01% | 536 |
|
2014
Q2 | – | Sell |
-700
| Closed | -$210K | – | 532 |
|
2014
Q1 | $210K | Buy |
+700
| New | +$210K | ﹤0.01% | 467 |
|
2013
Q3 | – | Sell |
-1,000
| Closed | -$225K | – | 371 |
|
2013
Q2 | $225K | Buy |
+1,000
| New | +$225K | ﹤0.01% | 343 |
|